Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX vs Zanaflex for Post-Stroke Upper Limb Spasticity
NCT00430196Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Dec 2003
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in Upper limb spasticity (3 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: wrist Modified Ashworth Score. Started Dec 2003; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Upper limb spasticity
Beyond the preview
Go deeper on NCT00430196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430196.